In terms of specific IgG antibody response ( Figures 4A – C ), RBD-specific antibody (2.42-fold) increased after the 3 rd dose compared with the 2 nd dose >90d group (1.29-fold), which was equivalent to the degree of the 2 nd dose group (2.07-fold) and showed an increasing trend.
← all excerpts
The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults.
1
—
—